MELANOMA, STAGE II
Clinical trials for MELANOMA, STAGE II explained in plain language.
Never miss a new study
Get alerted when new MELANOMA, STAGE II trials appear
Sign up with your email to follow new studies for MELANOMA, STAGE II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New copycat cancer drug faces keytruda in Head-to-Head test
Disease control OngoingThis study is testing whether a new biosimilar drug called FYB206 behaves similarly in the body to the established cancer drug Keytruda. The trial involves 96 patients with stage IIB/IIC or III melanoma who have had their cancer completely removed by surgery. Researchers want to …
Matched conditions: MELANOMA, STAGE II
Phase: PHASE1 • Sponsor: Formycon AG • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Tracking the hidden toll: study maps immunotherapy side effects in cancer survivors
Knowledge-focused OngoingThis study observes melanoma survivors who have completed surgery and are receiving immunotherapy drugs to prevent cancer return. Researchers follow 126 patients for two years to track side effects, symptoms like fatigue and depression, and quality of life. The goal is to underst…
Matched conditions: MELANOMA, STAGE II
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:01 UTC